Abbott Laboratories (XSWX:ABT) Total Debt per Share: CHF15.39 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
78 GF Score
Price CHF81.00
GF Value CHF104.95
View Full Analysis

What is Abbott Laboratories Total Debt per Share?

Abbott Laboratories XSWX:ABT +1.25% 78 Total Debt per Share is CHF15.39 as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 78/100 and a GF Value™ of CHF104.95.

CHF15.39 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Abbott Laboratories's Total Debt Per Share for the quarter that ended in Mar. 2026 was CHF15.39.

Abbott Laboratories Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Total Debt per Share Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.92 9.50 7.79 7.73 6.36

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.73 6.28 5.93 6.36 15.39
XSWX:ABT
78GF Score
Abbott Laboratories XSWX:ABT
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Total Debt per Share Calculation

Abbott Laboratories's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(8,628+2,417)/1,737
=6.36

Abbott Laboratories's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(23,334+3,471)/1,742
=15.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of CHF15.39 mean?
Abbott Laboratories (XSWX:ABT) has a Total Debt per Share of CHF15.39 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Total Debt per Share too high?
Abbott Laboratories' current Total Debt per Share is CHF15.39. Overall, Abbott Laboratories has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Total Debt per Share compare to SYK and MDT?
Abbott Laboratories' Total Debt per Share of CHF15.39 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Devices & Instruments company?
A good Total Debt per Share depends on the Medical Devices & Instruments industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Total Debt per Share is CHF15.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Total Debt per Share of CHF15.39. The stock's GF Value™ is CHF104.95, compared to a current price of CHF81.00 — trading 22.8% below its estimated fair value. The current Total Debt per Share is CHF15.39. Abbott Laboratories' overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Total Debt per Share is CHF15.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF81.00 is trading 22.8% below its estimated GF Value™ of CHF104.95.

Key valuation signals for XSWX:ABT:

  • Total Debt per Share: CHF15.39
  • GF Value™: CHF104.95 vs. price of CHF81.00 (22.8% below fair value)
  • GF Score™: 78/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
78GF Score

Get the complete analysis for XSWX:ABT

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF81.00
Price
CHF104.95
GF Value